Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 84 results for "ranbaxy lab"

Ranbaxy ex-bosses to challenge Rs2,562-cr fine for hiding info...

Malvinder and Shivinder Singh, the original promoters of Ranbaxy Laboratories, will challenge the order of a Singapore tribunal imposing a Rs2,562-crore ($400 million) penalty on them for concealing information from Japan's Daiichi Sankyo while ... Domain-B, 2 weeks ago

Bhupesh Bhandari: Listen to Dinesh Thakur

Dinesh Thakur, the Ranbaxy whistleblower, seems to be waging a lone battle against sub-standard medicine. After the Supreme Court threw out his plea that sought "the creation of a framework for the recall of drugs and a commission to examine faulty ...
 Smart Investor2 weeks ago
International Business Times

WHO Suspends Tuberculosis Drugs From Major Indian Supplier

The World Health Organization (WHO) reportedly suspended its approval of all tuberculosisproducts made at India's Svizera Labs citing unreliable manufacturing standards and quality management. The company is one of the largest suppliers of generic ...
 International Business Times2 months ago

Worldwide Respiratory Drugs Market by 2020 Analyzed Report

Global Respiratory Drugs Market 2016-2020 is latest research report adds on, The analysts forecast global respiratory drugs market to grow at a CAGR of 6.48% during the period 2016-2020. Asthma, COPD, allergic rhinitis, ...
 MyNewsDesk1 week ago Respiratory Drugs Market Global Research Report 2020  Before It's News1 week ago Global Respiratory Drugs Market 2016-2020  Research and Markets4 days ago Latest Report On Global Resipiratory Drugs Market to grow at a CAGR of 6.48% during the period 2016-2020.  MyNewsDesk1 week ago

No rewards, only grief: How drug whistle-blowers in India have to fight a long battle

Since 2014, Narayan Konduru Reddy has been relentlessly writing emails to drug regulators from the US to Europe asking them to investigate the malpractices he alleged of his former employer GVK Biosciences , a leading contract research firm based in ...
 Economic Times5 days ago
Business Standard India

Nifty may touch 9,000 by year end: Jimeet Modi

Jimeet Modi, CEO, SAMCO Securities in an interview with Tulemino Antao shares his view on trends in markets, March quarter earnings, monsoon and stocks to buy. The exit polls indicate that the BJP is likely to emerge victorious in the Assam ...
 Smart Investor6 days ago
India Infoline

Daily Market Strategy - Upbeat start; swings in store for indices

The outlook is a firm start. OMCs will be in focus after Petrol price was hiked by 83 paisa a litre and diesel by Rs 1.26 per litre. Results expected today include Glaxosmithkline Consumer Healthcare, Motherson Sumi Systems and Voltas. One ...
 India Infoline1 week ago Daily Market Strategy Friday the 13th: Nothing to worry really; flat start for indices  India Infoline1 week ago Daily Market Strategy Appearances of weakness! Flat start for Sensex, Nifty  India Infoline1 week ago Daily Market Strategy - Living in the moment! Sensex, Nifty set to smile at start  India Infoline2 weeks ago

Daily Market Strategy Pattern is weak! Lower opening in store for Sensex, Nifty

Existence is random. Has no pattern save what we imagine after staring at it for too long. No meaning save what we choose to impose. - Alan Moore As elections get underway today in Tamil Nadu, Kerala and Union Territory Puducherry, the BJP will ...
 India Infoline1 week ago

Can Indian pharma fight back?

Stocks of Indian pharmaceutical companies have taken a knock over the last year and this is reflected in the poor run of the S&P BSE Healthcare Index. While its defensive cousins such as FMCG and information technology indices closed with flat ...
 Hindu Business Line1 week ago Can Indian pharmafight back?  Hindu Business Line1 week ago Why pharma companies sell sub-standard stuff in India  Rediff.com2 weeks ago Sun Pharma Gains 14 Japanese Brands From Novartis in $293 Million Deal  Pharma Live1 month ago

Daily Market Strategy - Happy listing for Ujjivan! Flat start for indices

There is no duty we so much underrate as the as the duty of being happy. -Robert Louis Stevenson A happy listing lay in store for Ujjivan Financial Services, which witnessed robust demand for its IPO. The stellar debut of diagnostic chain ...
 India Infoline2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less